Stockreport

Vertex Pharma +4.3% on Exonics acquisition; Crispr rises on deal [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Vertex Pharma +4.3% on Exonics acquisition; Crispr rises on deal - CRISPR Therapeutics AG (NASDAQ:CRSP) | Seeking Alpha Healthcare | On the Move Vertex Pharma +4.3% on E [Read more]